Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin L Maresh

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
BMC Cancer|June 22, 2011
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survivalSara Huerta-Yepez, Nam K Yoon, Angeles Hernandez-Cueto, et al.
Molecular Cancer Therapeutics|January 23, 2014
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancerMaoyong Fu, Erin L Maresh, Gustavo F Helguera, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
Prostate cancer cell phenotypes based on AGR2 and CD10 expressionMelissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
Cancer Research|August 17, 2010
Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancerAik T Ooi, Vei Mah, Derek W Nickerson, et al.
Cell Reports|February 16, 2016
MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4Candice Sun Hong, Nicholas A Graham, Wen Gu, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
BMC Cancer|June 22, 2011
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survivalSara Huerta-Yepez, Nam K Yoon, Angeles Hernandez-Cueto, et al.
Molecular Cancer Therapeutics|January 23, 2014
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancerMaoyong Fu, Erin L Maresh, Gustavo F Helguera, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
Prostate cancer cell phenotypes based on AGR2 and CD10 expressionMelissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
Cancer Research|August 17, 2010
Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancerAik T Ooi, Vei Mah, Derek W Nickerson, et al.
Cell Reports|February 16, 2016
MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4Candice Sun Hong, Nicholas A Graham, Wen Gu, et al.
Pageof 3